Study Links Certain Cancers With Increased Risk of Guillain-Barré Syndrome

March 3rd 2022, 10:30pm


Not all Guillain-Barré cases are associated with infection, and studies have suggested a link between the rare disorder and certain cancers, including lymphomas.

With Natural Killer Cell Immunotherapy, Alloreactive Cell Dose May Be Predictive of Response

February 26th 2022, 4:00pm


Research has shown that adoptive immunotherapy using natural killer cells may be beneficial in leukemia treatment. The follow-up to a recent study found that the dose of alloreactive natural killer cells matters for treatment response.

Natural Killer Cell–Based Immunotherapy: A Less Toxic Treatment for Leukemia?

February 25th 2022, 9:00pm


A recent review examined natural killer–based therapies, a type of immunotherapy that holds promise for treating leukemia with less toxicity than currently available therapies.

From the Editor-in-Chief: From the Earth to the Moon (and Back)

February 16th 2022, 2:24pm


The president’s aim is a 50% reduction in age-adjusted cancer deaths by 2047. This goal seems audacious, but it is likely achievable.

Steven Pergam, MD, MPH, Discusses NCCN’s “Strong Preference” for mRNA Vaccines in Patients With Cancer to Prevent COVID-19

February 13th 2022, 5:00pm


A statement from NCCN’s Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis said that the panel “endorses vaccination for all eligible persons based on FDA-approved indications or emergency use authorization” and emphasized the need for everyone to be fully vaccinated—including third doses.

Trials for Cancer Immunotherapies Grow Significantly From 2017 to 2021

February 12th 2022, 6:37pm


While the number of trials for cancer immunotherapies grew significantly, combination therapies being studied increased while monotherapies decreased.

CAR T Cells Persist 10 Years After CLL Treatment, Hailed as "Cure"

February 3rd 2022, 11:00pm


Researchers, as well as a patient who had chronic lymphocytic leukemia (CLL), hailed the findings as a cure, although more work needs to be done to see if the results persist in a larger group of patients.

Most-Read AJAC Papers of 2021

December 27th 2021, 2:30pm


The most-read AJAC papers of 2021 analyze real-world programs to transform health care and provide insight into physician perspectives of health care and insurance.

Dr Peter Hotez on Combatting Antivaccination Beliefs and Rescuing Public Health From Politics

December 21st 2021, 8:04pm


In an interview conducted before the highly transmissible Omicron coronavirus variant began driving another wave of infections, Peter Hotez, MD, PhD, FASTMH, discussed the struggle public health officials and scientists have in fighting false beliefs about vaccinations.

Looking Ahead to 2022 With the Editors of AJMC®

December 21st 2021, 7:00pm


The editors of The American Journal of Managed Care® and The American Journal of Accountable Care® reflect on the past year and discuss the themes and topics they expect to see in 2022.